Earnings Feed
Start Free
Larimar Therapeutics, Inc.·4

May 18, 2:13 PM ET

BEN-MAIMON CAROLE 4

4 · Larimar Therapeutics, Inc. · Filed May 18, 2023

Insider Transaction Report

Form 4
Period: 2023-05-17
Larimar Therapeutics, Inc.LRMR
BEN-MAIMON CAROLE
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-05-17$3.71/sh+5,000$18,525→ 266,829 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES